Manufactures active pharmaceutical ingredients, intermediates, xanthine derivatives and CDMO services.
2019
India
1,001 - 5,000 employees
Pharmaceuticals
$100M - 500M in revenue
$25M - 100M in profitability
Margin as % of revenue
R&D as % of revenue
Not available
Not available
Not available
Not available
3 out of 10 incl. management
| Target | Status | Temperature alignment | Year |
|---|---|---|---|
| Near-term target | Targets set | 1.5°C | FY2029 |
| Long-term target | Targets set | 1.5°C | FY2049 |
| Net-zero | Targets set | - | 2050 |
| Business Ambition 1.5°C | Not disclosed | - | - |
Overall Net-Zero Target: Aarti Pharmalabs Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Aarti PharmaLabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 37.8% by FY2030 from a FY2024 base year.* Aarti PharmaLabs Limited also commits to reduce absolute scope 3 GHG emissions 22.5% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Aarti Pharmalabs Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* Aarti Pharmalabs Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Powered by illuminem and Science Based Targets initiative. Last updated: 17 Apr 2025| Target | Year | Value | Scope | Baseline |
|---|
Not available
Not available
Not available
Not available
Not available
Not available
Not available